Sadagopan Krishnan

Prof. Sadagopan Krishnan

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
JSJuliane R. Sempionatto
Juliane R. Sempionatto
Itthipon JeerapanItthipon Jeerapan
Itthipon Jeerapan
SKSadagopan Krishnan
Sadagopan Krishnan
Joseph WangJoseph Wang
Joseph Wang

12 February 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
VSVini Singh
Vini Singh
SKSadagopan Krishnan
Sadagopan Krishnan

1 June 2017 in Analytica Chimica Acta
Verified
Journal Article
Closed access
GPGayan Premaratne
Gayan Premaratne
SFSabrina Farias
Sabrina Farias
SKSadagopan Krishnan
Sadagopan Krishnan

5 December 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
VSVini Singh
Vini Singh
SKSadagopan Krishnan
Sadagopan Krishnan
An electrochemical mass sensor for clinically relevant detection of insulin in human serum conjugated to magnetic nanoparticles and captured onto antibody immobilized gold coated quartz resonators is reported for the first time.

25 November 2020 in Journal of the Electrochemical Society
Verified
Journal Article
Open access
PDF file
SKSadagopan Krishnan
Sadagopan Krishnan
Per the 2020 National Diabetes Statistics Report (2018 estimates), 34.2 million people of all ages (10.5% of the US population) had diabetes, and 88.0 million Americans (34.5% of all US adults) had prediabetes (an increase from 79 million in 2010). Diagnosed diabetic conditions cost the nation $327 billion in 2017, a 26% increase from the prior estimate of $245 billion in 2012. Thus, substantial health and economic burdens are placed on the nation and globally, added with the ongoing COVID-19 pandemic and its negative impacts on pre-existing health conditions (e.g., diabetic and autoimmune disorders). Our research goal is to contribute to the development of user-friendly, point-of-care sensors that would offer monitoring ultra-low clinically relevant levels of desired biomarkers by minimally invasive and non-invasive ways (e.g., picomolar serum/blood insulin, small molecules in urine, and large serum antibodies). We explored a wide range of surface chemistries and electroanalytical techniques for successfully measuring the described markers. Independent validations of our electrochemical sensors with surface plasmon resonance binding assays and commercial biological assays (although tedious and relatively more expensive than electrochemical approaches), and applications for real samples have been accomplished. Our ongoing efforts focus on new label-free point-of-care sensors for infectious disease markers.

1 November 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
GPGayan Premaratne
Gayan Premaratne
ADAsantha C. Dharmaratne
Asantha C. Dharmaratne
ZMZainab H. Al Mubarak
Zainab H. Al Mubarak
FMFarshid Mohammadparast
Farshid Mohammadparast
MAMarimuthu Andiappan
Marimuthu Andiappan
SKSadagopan Krishnan
Sadagopan Krishnan